BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26051784)

  • 1. New biaryl-chalcone derivatives of pregnenolone via Suzuki-Miyaura cross-coupling reaction. Synthesis, CYP17 hydroxylase inhibition activity, QSAR, and molecular docking study.
    Al-Masoudi NA; Kadhim RA; Abdul-Rida NA; Saeed BA; Engel M
    Steroids; 2015 Sep; 101():43-50. PubMed ID: 26051784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New CYP17 hydroxylase inhibitors: synthesis, biological evaluation, QSAR, and molecular docking study of new pregnenolone analogs.
    Al-Masoudi NA; Ali DS; Saeed B; Hartmann RW; Engel M; Rashid S; Saeed A
    Arch Pharm (Weinheim); 2014 Dec; 347(12):896-907. PubMed ID: 25251696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new pregnenolone analogues as privileged scaffolds in inhibition of CYP17 hydroxylase enzyme. Synthesis and in silico molecular docking study.
    Al-Masoudi NA; Mahdi KM; Abdul-Rida NA; Saeed BA; Engel M
    Steroids; 2015 Aug; 100():52-9. PubMed ID: 25988615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls.
    Hille UE; Hu Q; Vock C; Negri M; Bartels M; Müller-Vieira U; Lauterbach T; Hartmann RW
    Eur J Med Chem; 2009 Jul; 44(7):2765-75. PubMed ID: 19211174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, 17α-hydroxylase-C
    Banday AH; Shameem SA; Banday JA; Ganaie BA
    Anticancer Agents Med Chem; 2018; 18(13):1919-1926. PubMed ID: 29697032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel oxazolinyl derivatives of pregna-5,17(20)-diene as 17α-hydroxylase/17,20-lyase (CYP17A1) inhibitors.
    Kuzikov AV; Dugin NO; Stulov SV; Shcherbinin DS; Zharkova MS; Tkachev YV; Timofeev VP; Veselovsky AV; Shumyantseva VV; Misharin AY
    Steroids; 2014 Oct; 88():66-71. PubMed ID: 24971814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors.
    Gumede NJ; Nxumalo W; Bisetty K; Escuder Gilabert L; Medina-Hernandez MJ; Sagrado S
    Bioorg Chem; 2020 Jan; 94():103462. PubMed ID: 31818479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2.
    Hartmann RW; Hector M; Haidar S; Ehmer PB; Reichert W; Jose J
    J Med Chem; 2000 Nov; 43(22):4266-77. PubMed ID: 11063622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2.
    Fehl C; Vogt CD; Yadav R; Li K; Scott EE; Aubé J
    J Med Chem; 2018 Jun; 61(11):4946-4960. PubMed ID: 29792703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17-Hydroxylase and andien-beta synthetase activities in immature pig testis microsomal fraction: kinetic studies of the pregnenolone binding site and possible intermediates of the reactions.
    Lavallée J; Cooke GM
    J Steroid Biochem Mol Biol; 1993 Jul; 46(1):73-83. PubMed ID: 8338793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
    Auchus RJ; Miller WL
    Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid residue, Ala 105, confers 16alpha-hydroxylase activity to human cytochrome P450 17alpha-hydroxylase/17,20 lyase.
    Swart AC; Storbeck KH; Swart P
    J Steroid Biochem Mol Biol; 2010 Apr; 119(3-5):112-20. PubMed ID: 20043997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.
    Zolottsev VA; Tkachev YV; Latysheva AS; Kostin VA; Novikov RA; Timofeev VP; Morozevich GE; Kuzikov AV; Shumyantseva VV; Misharin AY
    Steroids; 2018 Jan; 129():24-34. PubMed ID: 29183745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation.
    Lin CJ; Cheng LC; Lin TC; Wang CJ; Li LA
    Biochem Pharmacol; 2014 Aug; 90(3):288-96. PubMed ID: 24875446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnenolonyl-α-glucoside exhibits marked anti-cancer and CYP17A1 enzymatic inhibitory activities.
    Chou FP; Hsu WC; Huang SC; Chang CY; Chiou YS; Tsai CT; Lyu JW; Chen WT; Wu TK
    Chem Commun (Camb); 2020 Feb; 56(11):1733-1736. PubMed ID: 31938799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis.
    Gobbi S; Hu Q; Zimmer C; Engel M; Belluti F; Rampa A; Hartmann RW; Bisi A
    J Med Chem; 2016 Mar; 59(6):2468-77. PubMed ID: 26938274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation.
    Ferla S; Aboraia AS; Brancale A; Pepper CJ; Zhu J; Ochalek JT; DeLuca HF; Simons C
    J Med Chem; 2014 Sep; 57(18):7702-15. PubMed ID: 25148392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of novel oxazoline derivatives of 17(20)e-pregna-5,17(20)-diene with cytochrome P450 17A1].
    Stulov SV; Dugin NO; Zharkova MS; Shcherbinin DS; Kuzikov AV; Shumyantseva VV; Misharin AY; Veselovsky AV
    Biomed Khim; 2016; 62(1):38-44. PubMed ID: 26973185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and evaluation of N-alkynylaminosteroids as potential CYP450 17A1 inhibitors].
    Panada JU; Faletrov YV; Frolova NS; Shkumatov VM
    Biomed Khim; 2019 Jun; 65(4):324-330. PubMed ID: 31436174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure.
    Jagusch C; Negri M; Hille UE; Hu Q; Bartels M; Jahn-Hoffmann K; Pinto-Bazurco Mendieta MA; Rodenwaldt B; Müller-Vieira U; Schmidt D; Lauterbach T; Recanatini M; Cavalli A; Hartmann RW
    Bioorg Med Chem; 2008 Feb; 16(4):1992-2010. PubMed ID: 18061460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.